NDC 63629-3207
Senna-Lax
Sennosides A And B
Senna-Lax is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Sennosides A And B.
| Product ID | 63629-3207_5a42b29a-d47a-4c3e-aeeb-d93415d715f9 |
| NDC | 63629-3207 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Senna-Lax |
| Generic Name | Sennosides A And B |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-05-04 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | SENNOSIDES A AND B |
| Active Ingredient Strength | 9 mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 63629-3207-1
100 TABLET, FILM COATED in 1 BOTTLE (63629-3207-1)
| Marketing Start Date | 2011-05-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63629-3207-1 [63629320701]
Senna-Lax TABLET, FILM COATED
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-05-04 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3207-5 [63629320705]
Senna-Lax TABLET, FILM COATED
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-05-04 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3207-3 [63629320703]
Senna-Lax TABLET, FILM COATED
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-05-04 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3207-4 [63629320704]
Senna-Lax TABLET, FILM COATED
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-05-04 |
| Inactivation Date | 2019-11-27 |
NDC 63629-3207-2 [63629320702]
Senna-Lax TABLET, FILM COATED
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-05-04 |
| Inactivation Date | 2019-11-27 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SENNOSIDES A AND B | 8.6 mg/1 |
OpenFDA Data
| SPL SET ID: | 1283a8ff-00f4-11af-4357-ae102066fe65 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
NDC Crossover Matching brand name "Senna-Lax" or generic name "Sennosides A And B"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-6522 | Senna-Lax | Sennosides |
| 15127-105 | Senna-Lax | Sennosides |
| 53041-159 | Senna-Lax | Sennosides |
| 55154-7643 | Senna-Lax | Sennosides |
| 55700-128 | Senna-Lax | SENNOSIDES A AND B |
| 55700-629 | Senna-Lax | Sennosides |
| 61919-205 | SENNA-LAX | SENNA-LAX |
| 63629-3207 | Senna-Lax | SENNOSIDES A AND B |
| 68788-6442 | Senna-Lax | Sennosides |
| 68788-9685 | Senna-Lax | Sennosides |
| 68998-373 | Senna-Lax | Sennosides |
| 42982-4441 | Bekunis Natures Gentle Stimulant Laxative | SENNOSIDES A AND B |
| 0536-1000 | Senexon | Sennosides A and B |
| 17856-1000 | Senexon | Sennosides A and B |
| 0904-6289 | Senna | Sennosides A and B |
| 17856-1107 | SENNA | SENNOSIDES A AND B |
| 17856-6289 | Senna | Sennosides A and B |
| 24451-289 | Senna | SENNOSIDES A AND B |
| 53807-556 | Senna | Sennosides A and B |
| 54162-007 | SENNA | SENNOSIDES A AND B |
| 68151-0648 | Senna | Sennosides A and B |
| 70166-636 | SENNA | SENNOSIDES A AND B |
| 66424-562 | SENNA Syrup | Sennosides A and B |
| 76518-100 | Sennazon | Sennosides A and B |
Trademark Results [Senna-Lax]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SENNA-LAX 73470768 1460560 Live/Registered |
Nature's Herbs, Inc. 1984-03-19 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.